Sampling error and reliability of liver biopsy in patients with non-alcoholic fatty liver disease (NAFLD).

被引:0
|
作者
Mendez, P [1 ]
Regev, A [1 ]
Molina, E [1 ]
Berho, M [1 ]
Bejarano, P [1 ]
Ladino, M [1 ]
Schiff, E [1 ]
机构
[1] Univ Miami, Miami, FL 33152 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1074
引用
收藏
页码:673A / 673A
页数:1
相关论文
共 50 条
  • [41] Liver disease severity and risk of kidney damage in patients with non-alcoholic fatty liver disease (NAFLD)
    Agrawal, Saurabh
    Lopez, Rocio
    Omo, Jason T.
    Conjeevaram, Hari S.
    GASTROENTEROLOGY, 2008, 134 (04) : A784 - A784
  • [42] Alteration in fatty acid composition in liver biopsies of patients with non-alcoholic fatty liver disease (NAFLD) compared to those with reported normal liver biopsy
    Allard, Johane. P.
    Aghdassi, Ellie
    Avand, Ghazal
    Prayitno, Nita R.
    Ma, David W.
    Nguyen, Augustin
    Raman, Maitreyi
    Guindi, Maha
    Sherman, Morris
    Heathcote, Jenny E.
    GASTROENTEROLOGY, 2006, 130 (04) : A595 - A595
  • [43] The Role of Liver Biopsy to Assess Non-Alcoholic Fatty Liver Disease
    Kobyliak, Nazarii
    Abenavoli, Ludovico
    REVIEWS ON RECENT CLINICAL TRIALS, 2014, 9 (03) : 159 - 169
  • [44] Role of liver biopsy in the assessment of non-alcoholic fatty liver disease
    Hübscher, SG
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (11) : 1107 - 1115
  • [45] Is visfatin a protective adipokine in patients with non-alcoholic fatty liver disease (NAFLD)?
    Jarrar, Mohammed
    Elariny, Hazem A.
    Collantes, Rochelle S.
    Nugent, Clare
    Fang, Yun
    Stepanova, Maria
    Kopparti, Nirupama
    Goodman, Zachary D.
    Chandhoke, Vikas
    Baranova, Ancha
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2007, 132 (04) : A819 - A820
  • [46] Cytokines and oxidative stress in patients with non-alcoholic fatty liver disease (NAFLD)
    Kumar, A.
    Kumar, R.
    Madan, K.
    Prakash, S.
    Sreenivas, V.
    Acharya, S. K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A100 - A100
  • [47] Long Term Mortality of Patients with Non-alcoholic Fatty Liver Disease (NAFLD)
    Golabi, Pegah
    Otgonsuren, Munkhzul
    Arsalla, Aimal
    Erario, Madeline
    Srishord, Manirath
    Younossi, Zobair M.
    HEPATOLOGY, 2016, 64 : 529A - 530A
  • [48] Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences
    Tripodi, Armando
    Lombardi, Rosa
    Primignani, Massimo
    La Mura, Vincenzo
    Peyvandi, Flora
    Fracanzani, Anna L.
    BIOMEDICINES, 2022, 10 (02)
  • [49] The role of bacterial overgrowth in patients with non-alcoholic fatty liver disease (NAFLD)
    Treiber, Gerhard
    Weigt, Jochen
    Kolfenbach, Sven
    Leodolter, Andreas
    Malfertheiner, Peter
    GASTROENTEROLOGY, 2006, 130 (04) : A823 - A823
  • [50] The evolving role of liver biopsy in non-alcoholic fatty liver disease
    Pablo Arab, Juan
    Barrera, Francisco
    Arrese, Marco
    ANNALS OF HEPATOLOGY, 2018, 17 (06) : 899 - 902